AzTrials
AzTrials

Wound HealingNCT06760403

Efficacy of Hypochlorous Acid as a Postoperative Wound Antiseptic

A study testing Hypochlorous acid in people with Wound Healing, run by Ataturk University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim was to examine the effectiveness of hypochlorous acid on postoperative wound healing in 24 systemically healthy gingivectomy participants aged 12-30. The participants were divided into 3 groups as hypochlorous acid group, chlorhexidine group and saline group and their wound healing was evaluated on the 1st… Read more about this study

Who is it for?
Ages 12 to 30 yearsHealthy volunteers can take part
Conditions the study is for
Wound Healing
What is being tested?
Hypochlorous acid
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
24 participants
Where
1 siteTurkey (Türkiye)
Study dates
2 May 2023to 1 Dec 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 12 to 30 years
  • All sexes
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Gingival overgrowth affecting at least six teeth symmetrically in the mandibular or maxillary anterior area
  • No attachment and bone loss
  • 7 days before the surgery, full-mouth plaque index (PI) < 25% and a full-mouth gingival bleeding index (GBI) < 25%.
  • the keratinized tissues surrounding the teeth are at least 2 mm wide.

Who cannot join

  • Smoking or alcohol use
  • Patients who have undergone systemic antimicrobial therapy and surgical procedures within the last 3 months
  • Pregnancy or lactation
  • Immunodeficiency or immunosuppressive drug therapy

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Atatürk University Faculty of Dentistry

    Erzurum, 25240

Other trials in Turkey (Türkiye)

About this study

Official title: Investigation of the Efficacy of Hypochlorous Acid as a Postoperative Wound Antiseptic: A Randomized Controlled Pilot Study

The aim was to examine the effectiveness of hypochlorous acid on postoperative wound healing in 24 systemically healthy gingivectomy participants aged 12-30. The participants were divided into 3 groups as hypochlorous acid group, chlorhexidine group and saline group and their wound healing was evaluated on the 1st, 3rd and 7th days.

Read the detailed description

The aim of this study was to investigate the effectiveness of hypochlorous acid on postoperative wound healing in 24 participants aged 12-30 who underwent gingivectomy involving the 6 anterior teeth of the upper or lower jaw with chronic inflammatory gingival overgrowth. The participants were divided into 3 groups as hypochlorous acid group, chlorhexidine group and saline group and were called for control on the 1st, 3rd and 7th days to evaluate wound healing. Periodontal indexes, visual analog scale (VAS), H2O2, plaque staining agent test, and histological analyzes were used to evaluate wound healing. The data were analyzed statistically.

Conditions
Wound Healing
Being tested
Hypochlorous acid
Keywords
gingival overgrowth, gingivoplasty, gingivectomy, hypochlorous acid, chlorhexidine
Medical subject headings
Gingival Overgrowth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Hypochlorous acidDrug

    Hypochlorous acid, chlorhexidine and saline groups were compared as postoperative gargles after gingivectomy surgery.

Study groups in NCT06760403
Study groupRoleWhat they receive
Hypochlorous GroupExperimentalIn the hypochlorous acid group, 15 ml was used as a postoperative gargle, 2 times * 7 days.
Receives: Drug: Hypochlorous acid
Chlorhexidine GroupActive comparatorIn the clorhexidine group, 15 ml was used as a postoperative gargle, 2 times * 7 days.
Receives: Drug: Hypochlorous acid
Saline GroupPlacebo comparatorIn the saline group, 15 ml was used as a postoperative gargle, 2 times * 7 days.
Receives: Drug: Hypochlorous acid

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Plaque index

    The amount of plaque was scored.

    Measured: Baseline, Day 7

  2. Gingival index

    The gingival status was scored.

    Measured: Baseline, Day 7

  3. Probing depth

    The periodontal pocket depth was performed (mm).

    Measured: Baseline, Day 7

  4. Clinical attachment level

    The clinical attachment level was measured (mm).

    Measured: Baseline, Day 7

  5. Bleeding on probing

    The gingival status was scored.(%)

    Measured: Baseline, Day 7

  6. Epithelialization with plaque staining agent

    The wound surface epithelialization was observed with plaque staining agent. The wound surface was stained with plaque staining dye and the dark colored area is calculated as mm2.

    Measured: Day 1, 3, and 7

  7. Epithelialization with H2O2

    The wound surface epithelialization was observed with H2O2. Scored as foaming present/absent after application with H2O2

    Measured: Day 3 and 7

  8. Histological analysis

    Histological analysis evaluated epithelial keratinization, regeneration, and/or degeneration during the healing process and to obtain epithelial samples repeatedly. The number of keratinocytes was counted.

    Measured: Day 1, 3, and 7

  9. postoperative pain with Visiual Analogue Scale (VAS)

    VAS scores were taken on the 3rd and 7th days without any intervention to the patient. Scored between 1-10 as 1 was no pain, 10 was pain.

    Measured: Day 3 and 7

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted6 Jan 2025
  2. Study start2 May 2023
  3. Primary completion2 Oct 2023
  4. Study completion1 Dec 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The study included 24 systemically healthy individuals who were randomly divided into three groups: 1) Hypochlorous acid, 2) Chlorhexidine, and 3) Saline.
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06760403
Sponsor's protocol ID
MCT4
Status last verified
Jan 2025
First submitted
24 Dec 2024
Last updated
6 Jan 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Burian EA, Sabah L, Kirketerp-Moller K, Gundersen G, Agren MS. Effect of Stabilized Hypochlorous Acid on Re-epithelialization and Bacterial Bioburden in Acute Wounds: A Randomized Controlled Trial in Healthy Volunteers. Acta Derm Venereol. 2022 May 31;102:adv00727. doi: 10.2340/actadv.v102.1624.

    PubMed 35578822

Questions about this trial

What is this clinical trial studying?

A study testing Hypochlorous acid in people with Wound Healing, run by Ataturk University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 6 Jan 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Plaque index (time frame: Baseline, Day 7). The study lists 9 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT06760403, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 6 Jan 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in